UBS O'Connor’s Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CRU.WS Stock Holding History

UBS O'Connor’s Portfolio CRU.WS Stock Details CRU.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-165,621	Closed	-$16K	–	1047
2022 Q2	$16K	Buy	+165,621	New	+$30.8K	﹤0.01%	925
2022 Q1	–	Sell	-162,691	Closed	-$116K	–	797
2021 Q4	$116K	Buy	162,691 +4,363	+3%	+$3.54K	﹤0.01%	817
2021 Q3	$134K	Hold	158,328	–	–	﹤0.01%	785
2021 Q2	$164K	Hold	158,328	–	–	﹤0.01%	761
2021 Q1	$220K	Buy	+158,328	New	+$247K	﹤0.01%	676

Other funds holding CRU.WS

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

UBS O'Connor's CRU.WS Position: Q3 2022 in Review

UBS O'Connor sold out of Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CRU.WS) in Q3 2022, closing a stake of 165,621 shares — an estimated $16K sold.

UBS O'Connor first reported a position in CRU.WS in Q1 2021 and held it in 5 quarters. The position peaked at $220K in Q1 2021. 8 funds tracked by Wall St. Rank hold CRU.WS as of Q3 2022.

UBS O'Connor reported no remaining Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
UBS O'Connor sold 165,621 Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q3 2022, an estimated $16K.
UBS O'Connor first reported a position in Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2021 and held it in 5 quarters.
UBS O'Connor's Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $220K in Q1 2021.
8 funds tracked by Wall St. Rank held Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q3 2022.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.